
With an increase in anxiety and depression symptomatology, mental health appears to have worsened globally and in the U.S. among many groups during the first few years of the pandemic [1–6]. Research indicates that death of a loved one, job loss and increased isolation may be some of the drivers...

Our study is one of the first that assessed infection-induced, vaccine-induced and hybrid immunity and neutralizing activity of antibodies against SARS-CoV-2 in a larger population-based sample. The population-based cohort study showed that by mid-2022, SARS-CoV-2 has become endemic and the levels of...

Since the declaration of the pandemic situation in March 2020 by the WHO and as of May 24, 2023, more than 6.9 million deaths in connection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection have been registered worldwide [1]. A critical phase of infection is the...

Parosmia is a known symptom of coronavirus‐2019 (COVID‐19) infection, with 30% to 75% of affected patients noting long‐term parosmia. For those affected by parosmia, there are limited treatment options and long‐term prognosis remains unclear.1,2 Although studies have suggested...

The coronavirus disease 2019 (COVID-19) pandemic led to socially disadvantaged populations being more vulnerable to risks and threats related to this public health crisis, especially during the early stages of the pandemic [1–3]. The disparities are exacerbated for people facing socioeconomic disadvantages...